Newsroom

Alzheimer's Matters Blog

Developing Drugs

CTAD Showcases ADDF Leadership and Historic Progress in Alzheimer’s Research

The 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference has been a truly historic meeting, and the Alzheimer’s Drug Discovery Foundation (ADDF)’s role in bringing about a new era of research was evident throughout.

ADDF Impact

Celebrating Alzheimer’s Science and Scientists at the 2022 ADDF Goodes Prize Luncheon

Five previous winners of the prestigious Melvin R. Goodes Prize came together in New York City recently to honor this year’s winner, Miranda E. Orr, PhD, Assistant Professor of Gerontology and Geriatric Medicine at the Wake Forest University School of Medicine, and to discuss how their research is working toward the same goal – to conquer Alzheimer’s.

Protecting Brain Health

Can Lifestyle Interventions Combined with a Diabetes Drug Prevent Cognitive Decline?

Alzheimer’s Drug Discovery Foundation Funds Second Phase of Global Alzheimer’s Prevention FINGER TRIAL

Resources

Featured Video

On April 9, the ADDF celebrated its second annual Memories Matter benefit event at Chelsea Piers, which welcome nearly 600 guests and raised over $1 million for Alzheimer's research.

View more on our YouTube channel

Fact Sheets & Publications